Gilead Sciences Inc (GILD)
Mexican Exchange · Mexico · prices in MXN · close of 22 Oct 2026
Key indicators
| Last close | MXN 2,910.00 |
|---|---|
| 52-week range | 2,116.00 – 2,940.00 |
| Return, 1 month / 3 months | +10.2% / +28.6% |
| Return, 1 year / 3 years | +31.2% / +128.7% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 26.0% |
| Worst drawdown (1 year) | -18.7% |
| Average daily value traded | 2.57M MXN |
| Dividend yield | 2.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gilead Sciences is a biopharmaceutical company based in California that researches, develops and makes medicines for serious illnesses. Its main products are antiviral treatments for HIV and viral hepatitis, along with therapies in areas such as cancer and inflammatory disease. It serves patients and healthcare providers through hospitals, clinics and pharmacies, mainly in the United States and Europe, and works with partners to make its medicines available in other markets around the world.
On this site Gilead Sciences Inc appears as a stock on the Mexican Exchange (Mexico), code GILD, with prices in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gilead Sciences Inc (GILD) trades on the Mexican Exchange in Mexico. It last closed at MXN 2,910.00 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 34 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.2% and over the last three months it rose 28.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.1% | ||
| From 52-week high | -0.5% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 28.6% | ||
| 6-month return | 24.9% | ||
| 12-month return, skipping the last month | 19.0% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.7% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 2.57M MXN | ||
| Zero-volume days | 51.7% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.0% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | +10.2% |
| 3 months | +28.6% |
| 6 months | +24.9% |
| 1 year | +31.2% |
| 3 years | +128.7% |
| 5 years | +157.9% |
Signals
| 50-day / 200-day average | 2,572.09 / 2,383.14 |
|---|---|
| Golden / death cross (60 days) | Golden, 34 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 34.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Sep 2026 | MXN 14.0583 |
| 15 Jun 2026 | MXN 14.1052 |
| 13 Mar 2026 | MXN 14.7129 |
| 15 Dec 2025 | MXN 14.2014 |
| 15 Sep 2025 | MXN 14.5127 |
| 13 Jun 2025 | MXN 14.9772 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.